The Asia Pacific Cell Viability Assays Market should witness market growth of 10.7% CAGR during the forecast period (2022-2028).
Identifying the most suitable health assay method that suits the user's requirement requires a proper understanding of the limitations of the assay chemistries, what each assay is measuring as a marker and how the measurement correlates with the cell viability.
Users also choose multiplex-compatible assays to gain more data with a statistical advantage. Cell viability assays indicate metabolically active (living) cells using different markers. Some examples of marker that are generally utilized include measuring ATP levels, detecting enzymatic/protease activities unique to living cells, and measuring the ability to reduce a substrate.
Real-time cell viability assays are utilized to measure the live viability of cells. An engineered prosubstrate and a luciferase are included directly in the culture medium for this assay. The prosubstrate can enter the cell by piercing the cell membrane. However, the prosubstrate can be reduced to the substrate for luciferase only by those viable cells with an active metabolism.
The government of India launched the Free Essential Diagnostics Initiatives under the National health mission to highlight the high out-of-pocket expenditure on diagnostics and enhance the quality of healthcare service quality. The government has launched “Free Diagnostics Services” initiative with the aim to ensure the access and availability of diagnostic tests at public health facilities to reduce out-of-pocket spending by patients on diagnostics.
The China market dominated the Asia Pacific Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $194.9 million by 2028. The Japan market is experiencing a CAGR of 10% during (2022-2028). Additionally, The India market would display a CAGR of 11.4% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
Identifying the most suitable health assay method that suits the user's requirement requires a proper understanding of the limitations of the assay chemistries, what each assay is measuring as a marker and how the measurement correlates with the cell viability.
Users also choose multiplex-compatible assays to gain more data with a statistical advantage. Cell viability assays indicate metabolically active (living) cells using different markers. Some examples of marker that are generally utilized include measuring ATP levels, detecting enzymatic/protease activities unique to living cells, and measuring the ability to reduce a substrate.
Real-time cell viability assays are utilized to measure the live viability of cells. An engineered prosubstrate and a luciferase are included directly in the culture medium for this assay. The prosubstrate can enter the cell by piercing the cell membrane. However, the prosubstrate can be reduced to the substrate for luciferase only by those viable cells with an active metabolism.
The government of India launched the Free Essential Diagnostics Initiatives under the National health mission to highlight the high out-of-pocket expenditure on diagnostics and enhance the quality of healthcare service quality. The government has launched “Free Diagnostics Services” initiative with the aim to ensure the access and availability of diagnostic tests at public health facilities to reduce out-of-pocket spending by patients on diagnostics.
The China market dominated the Asia Pacific Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $194.9 million by 2028. The Japan market is experiencing a CAGR of 10% during (2022-2028). Additionally, The India market would display a CAGR of 11.4% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
Scope of the Study
By Product
- Consumables
- Reagents & Assay Kits
- Luminometric Assays
- Dye Exclusion Assays
- Colorimetric Assays
- Fluorometric Assays
- Microplates
- Reagents & Assay Kits
- Instruments
- Spectrophotometer
- Microscopy
- Cell Imaging & Analysis System
- Flow Cytometry
- Others
By End-user
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Diagnostic Labs
By Application
- Stem Cell Research
- Drug Discovery & Development
- Diagnostics
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cell Viability Assays Market, by Product
1.4.2 Asia Pacific Cell Viability Assays Market, by End User
1.4.3 Asia Pacific Cell Viability Assays Market, by Application
1.4.4 Asia Pacific Cell Viability Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Cell Viability Assays Market by Product
4.1 Asia Pacific Consumables Market by Country
4.2 Asia Pacific Cell Viability Assays Market by Consumables Type
4.2.1 Asia Pacific Reagents & Assay Kits Market by Country
4.2.2 Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type
4.2.2.1 Asia Pacific Luminometric Assays Market by Country
4.2.2.2 Asia Pacific Dye Exclusion Assays Market by Country
4.2.2.3 Asia Pacific Colorimetric Assays Market by Country
4.2.2.4 Asia Pacific Fluorometric Assays Market by Country
4.2.3 Asia Pacific Microplates Market by Country
4.3 Asia Pacific Instruments Market by Country
4.4 Asia Pacific Cell Viability Assays Market by Instruments Type
4.4.1 Asia Pacific Spectrophotometer Market by Country
4.4.2 Asia Pacific Microscopy Market by Country
4.4.3 Asia Pacific Cell Imaging & Analysis System Market by Country
4.4.4 Asia Pacific Flow Cytometry Market by Country
4.4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Cell Viability Assays Market by End-user
5.1 Asia Pacific Biopharmaceutical & Pharmaceutical Companies Market by Country
5.2 Asia Pacific CROs & CMOs Market by Country
5.3 Asia Pacific Academic & Research Institutes Market by Country
5.4 Asia Pacific Diagnostic Labs Market by Country
Chapter 6. Asia Pacific Cell Viability Assays Market by Application
6.1 Asia Pacific Stem Cell Research Market by Country
6.2 Asia Pacific Drug Discovery & Development Market by Country
6.3 Asia Pacific Diagnostics Market by Country
Chapter 7. Asia Pacific Cell Viability Assays Market by Country
7.1 China Cell Viability Assays Market
7.1.1 China Cell Viability Assays Market by Product
7.1.1.1 China Cell Viability Assays Market by Consumables Type
7.1.1.1.1 China Cell Viability Assays Market by Reagents & Assay Kits Type
7.1.1.2 China Cell Viability Assays Market by Instruments Type
7.1.2 China Cell Viability Assays Market by End-user
7.1.3 China Cell Viability Assays Market by Application
7.2 Japan Cell Viability Assays Market
7.2.1 Japan Cell Viability Assays Market by Product
7.2.1.1 Japan Cell Viability Assays Market by Consumables Type
7.2.1.1.1 Japan Cell Viability Assays Market by Reagents & Assay Kits Type
7.2.1.2 Japan Cell Viability Assays Market by Instruments Type
7.2.2 Japan Cell Viability Assays Market by End-user
7.2.3 Japan Cell Viability Assays Market by Application
7.3 India Cell Viability Assays Market
7.3.1 India Cell Viability Assays Market by Product
7.3.1.1 India Cell Viability Assays Market by Consumables Type
7.3.1.1.1 India Cell Viability Assays Market by Reagents & Assay Kits Type
7.3.1.2 India Cell Viability Assays Market by Instruments Type
7.3.2 India Cell Viability Assays Market by End-user
7.3.3 India Cell Viability Assays Market by Application
7.4 South Korea Cell Viability Assays Market
7.4.1 South Korea Cell Viability Assays Market by Product
7.4.1.1 South Korea Cell Viability Assays Market by Consumables Type
7.4.1.1.1 South Korea Cell Viability Assays Market by Reagents & Assay Kits Type
7.4.1.2 South Korea Cell Viability Assays Market by Instruments Type
7.4.2 South Korea Cell Viability Assays Market by End-user
7.4.3 South Korea Cell Viability Assays Market by Application
7.5 Singapore Cell Viability Assays Market
7.5.1 Singapore Cell Viability Assays Market by Product
7.5.1.1 Singapore Cell Viability Assays Market by Consumables Type
7.5.1.1.1 Singapore Cell Viability Assays Market by Reagents & Assay Kits Type
7.5.1.2 Singapore Cell Viability Assays Market by Instruments Type
7.5.2 Singapore Cell Viability Assays Market by End-user
7.5.3 Singapore Cell Viability Assays Market by Application
7.6 Malaysia Cell Viability Assays Market
7.6.1 Malaysia Cell Viability Assays Market by Product
7.6.1.1 Malaysia Cell Viability Assays Market by Consumables Type
7.6.1.1.1 Malaysia Cell Viability Assays Market by Reagents & Assay Kits Type
7.6.1.2 Malaysia Cell Viability Assays Market by Instruments Type
7.6.2 Malaysia Cell Viability Assays Market by End-user
7.6.3 Malaysia Cell Viability Assays Market by Application
7.7 Rest of Asia Pacific Cell Viability Assays Market
7.7.1 Rest of Asia Pacific Cell Viability Assays Market by Product
7.7.1.1 Rest of Asia Pacific Cell Viability Assays Market by Consumables Type
7.7.1.1.1 Rest of Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type
7.7.1.2 Rest of Asia Pacific Cell Viability Assays Market by Instruments Type
7.7.2 Rest of Asia Pacific Cell Viability Assays Market by End-user
7.7.3 Rest of Asia Pacific Cell Viability Assays Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Bio-Rad laboratories, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.5 PerkinElmer, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 Merck KGaA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Abcam plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Promega Corporation
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Creative Bioarray
8.9.1 Company Overview
8.10. Biotium, Inc.
8.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Methodology
LOADING...
